{"id":6819,"date":"2015-01-05T21:26:33","date_gmt":"2015-01-05T21:26:33","guid":{"rendered":"http:\/\/www.iiar-anticancer.org\/conference\/?page_id=6819"},"modified":"2024-01-30T18:53:35","modified_gmt":"2024-01-30T18:53:35","slug":"tuesday-october-7","status":"publish","type":"page","link":"https:\/\/conferences.iiar-suppl.com\/?page_id=6819","title":{"rendered":"Tuesday, October 7"},"content":{"rendered":"<h3><span style=\"color: #666699;\">Tuesday, October 7<\/span><\/h3>\n<p>(The presenters of <span style=\"color: #999999;\">gray titles<\/span> did not allow the online appearance of their lectures )<\/p>\n<hr style=\"width: 100%; color: #ffffff; border: 3px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>22. MOLECULAR AND CELLULAR BIOLOGY OF CANCER<\/h4>\n<h5><span style=\"color: #666699;\">ROOM A, 08.00-12.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: R.M. Hoffman, F.E. Ahmed, P. Kumar<br \/>\n<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_A\/Hoffman\/Hoffman.html\" target=\"_blank\" rel=\"noopener\">Cell cycle decoy with Salmonella typhimurium A1-R to convert tumors from chemo-resistant to sensitive. S. Yano, M. Zhao, T. Fujiwara, <em>R.M. Hoffman<\/em> (San Diego, CA, USA; Okayama, Japan) (30\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_A\/Wan\/Wan.html\" target=\"_blank\" rel=\"noopener\">Desmoglein 3 acts as a mechanosensor in response to environmental mechanical property. <em>H. Wan,<\/em> F. Kenny, J. Connelly (London, UK) (20\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Redox regulation of the cell cycle in health and disease. P.C.Goswami (Iowa City, IA, USA) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">A new target of Ras-signaling pathway that promotes angiogenesis in aggressive breast cancer. <em>B.K. Ray<\/em>, A. Ray (Columbia, MO, USA) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_A\/Ahmed\/Ahmed.html\" target=\"_blank\" rel=\"noopener\">RT-QPCR and its application to medicine and molecular biology. <em>F.E. Ahmed<\/em>, N.C. Ahmed (Greenville, NC, USA) (30\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">A physiological <em>in vivo<\/em> model for neuroectodermal child-cancer. I.Hultman, <em>L. \u00c4hrlund-Richter<\/em> (Stockholm, Sweden) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">The expression and the role of glutamate receptors in cancer. A. Stepulac (Lublin, Poland) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Wnt signaling as a target of anti-breast cancer drug discovery. V.L. Katanaev (Lausanne, Switzerland) (25&#8242;)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>23. HOX GENES IN CANCER<br \/>\nSpecial Symposium Organized by C. Aukim-Hastie and R. Morgan<\/h4>\n<h5><span style=\"color: #666699;\">ROOM A, 13.00-16.20 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: R. Morgan, C. Aukim-Hastie<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Introduction: R. Morgan(10\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">HOX transcription factors are potential targets and markers in malignant mesothelioma. <em>R. Morgan<\/em>, S. Gray, C. Gillett, Z. Tabi, F. Launchbury, J. Spicer, K. Harrington, H.S. Pandha (Guilford; London; Cardiff, UK) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">HOX genes in head and neck squamous cell carcinoma (HNSCC). K.D. Hunter (Sheffield, UK) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Targeting the HOX transcription factors and CD71 in multiple myeloma. T.R. Daniels, I.I. Neacato, J.A. Rodr\u00edguez, H.S. Pandha, R. Morgan, <em>M.L. Penichet<\/em> (Los Angeles, CA, USA; Guildford, UK) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Giving birth to blood stem cells, in vitro: HOXB4 promotes hematopoiesis during pluripotent stem cell differentiation by increasing the pool of hemogenic endothelium cells. N. Teichweyde, L.Kasperidus, S. Skibbe, P. Horn, <em>H. Klump<\/em> (Essen, Germany) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Investigating the role of homeobox genes in breast cancer stem cell function. M. Shah, R. Emes,A. Grabowska, <em>C. Allegrucci<\/em> (Loughborough; Nottingham, UK) (20 \u2018)<\/span><\/li>\n<li><span style=\"color: #888888;\">Candidate drug screening in HOX-related models of AML. C.L. Burt, L.M.J. Kettyle, N.M. Mulgrew, J.M. Ramsey, G.J. Dickson, <em>A. Thompson<\/em> (Belfast; London, UK) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">The abrogation of the HOXB7\/PBX2 complex induces apoptosis in melanoma through the MIR-221&amp;222-C-FOS pathway. <em>M.C. Errico<\/em>, F. Felicetti, L. Bottero, G. Mattia, N. Felli, M. Petrini, M. Bellengh, H.S. Pandha, R. Morgan, A. Car\u00e8(Rome, Italy; Guilford, UK) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">HOX gene expression in ovarian cancer. <em>A. Michael,<\/em> Z.L. Kelly, C.S. Moller-Levet, H. Pandha, R. Morgan (Guildford,UK) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Closing remarks : R. Morgan(5\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>24. ONCOGENES; TUMOR SUPPRESSOR GENES; GROWTH FACTORS; SIGNAL TRANSDUCTION<\/h4>\n<h5><span style=\"color: #666699;\">ROOM A, 16.30-19.45 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: T.G. Cotter, R. Todorova<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_A\/Cotter\/Cotter.html\" target=\"_blank\" rel=\"noopener\">Oncogene driven redox survival signalling in tumour cells. <em>T.G. Cotter,<\/em> J. Stanicka, W. Laundry (Cork, Ireland) (30\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Functional domains and IPD targeted therapy for Ewing\u2019s sarcoma. R. Todorova (Sofia, Bulgaria) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_A\/Wozniak\/Wozniak.html\" target=\"_blank\" rel=\"noopener\">The oxidative stress-associated SRC activator and C-SRC tyrosine kinase- novel targets in the mechanism of photodynamic therapy. <em>M. Wozniak<\/em>, K. Dus-Szachniewicz, B. Zi\u00f3lkowska, P. Zi\u00f3lkowski (Wroclaw, Poland) (10\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Identification and targeting pathways involved in the development of Merlin-deficient tumours. <em>S. Ammoun<\/em>, L. Provenzano, L. Zhou, M.C. Schmid, C.O Hanemann (Plymouth, Devon, UK) (40\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_A\/Zhou\/Zhou.html\" target=\"_blank\" rel=\"noopener\">Thioredoxin reductases 1: A key member in metabolism newly identified as prognostic and targetable in non-small cell lung cancer (NSCLC). Y. Zhang, <em>M. Zhou<\/em>, H. Zeng, W. Jiang, Y. Li, W. Ma, Y. Qiu, R. Guan, C. Zhou, L. Zeng, L. Liu, Y. Xiong, N. Yang (Changsha; Beijing, China PR) (10\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Gastric cancer in Morocco: Novel therapeutic targets. <em>H. Amrani Hassani Joutei<\/em>, N. Marchoudi, W. Mahfoud, I. Sadaoui, H. Lebrazi, T. Fechtali, H. Benomar (Casablanca; Mohammedia, Morocco) (30\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>25. SERUM MARKERS IN DIAGNOSIS AND THERAPY<br \/>\nISOBM. Special Symposium Organized by R. Molina and V. Barak<\/h4>\n<h5><span style=\"color: #666699;\">ROOM B, 8.00-10.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: R. Klapdor, R. Molina, V. Barak<br \/>\n<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Comparison of 3 different immunoassays for determination of CA 19-9 in pancreatic cancer patients &#8211; a new aspect of potentially clinical relevance. <em>R. Klapdor,<\/em> M. Bahlo (Hamburg, Germany) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Tumor markers in lung cancer, a tool for early diagnosis? <em>R. Molina<\/em>, R.M. Marrades, J.M. Aug\u00e9, J.M. Escudero, N. Vi\u00f1olas, N. Reguart, J. Ramirez, X. Filella, L. Molins, A. Agusti (Barcelona,Spain) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Prognostic significance of tumor markers in breast cancer. <em>V. Barak<\/em>, B. Uziely, A. Hubert, I. Kalichman, R. Einarsson, T. Peretz (Jerusalem, Israel) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Liquid biopsy \u2013 new perspectives for prediction and monitoring of therapy response in cancer patients. S. Holdenrieder (Bonn, Germany) (30\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>26. SERUM MARKERS IN DIAGNOSIS AND THERAPY<\/h4>\n<h5><span style=\"color: #666699;\">ROOM B, 10.10-12.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: R. Klapdor, S. Holdenrieder, V. Barak<br \/>\n<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Biomarkers for malignant melanoma \u2013treatment response assessment and metastasis prediction. <em>V. Barak,<\/em> S. Frenkel, S. Merims, M. Lotem, T. Peretz, I. Kalichman, J. Pe&#8217;er (Jerusalem, Israel) (30&#8242;)<\/span><\/li>\n<li><span style=\"color: #888888;\">Histone modifications in circulating nucleosomes as potential new biomarkers in cancer. <em>U. Gezer<\/em>, E.E. Y\u00f6r\u00fcker, M. Keskin, S. Holdenrieder, N. Dalay (Istanbul, Turkey) (15\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Roles of caveolin-1 and cyclooxygenase 2 in kidney, ureter, bladder and prostate cancers. <em>W.-S. Chang<\/em>, C.-W. Tsai, C.-M. Hsu, D.-T. Bau (Taichung, Taiwan) (15\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Practical experience of the fecal hemoglobin immunochemical test in a colorectal cancer screening program. J.M. Auge (Barcelona, Spain) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Determination of neopterin, kynurenine and tryptophan as immune system activation markers in various biological fluids. <em>L. Kujovsk\u00e1 Krcmov\u00e1,<\/em> B. Cervinkov\u00e1, D. Solichov\u00e1, B. Melichar, L. Sobotka, P. Solich (Kr\u00e1lov\u00e9, Czech Republic) (15\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>27. SERUM MARKERS IN DIAGNOSIS AND THERAPY<\/h4>\n<h5><span style=\"color: #666699;\">ROOM B, 13.00-15.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: K.J. Syrj\u00e4nen, O. Topolcan<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_B\/Syrjanen\/Syrjanen.html\" target=\"_blank\" rel=\"noopener\">A non-invasive diagnosis of gastric cancer (GC) precursors (Helicobacter pylori infection and atrophic gastritis) by an ELISA-test (GastroPanel\u00ae) measuring 4 stomach-specific biomarkers in the blood. K.J. Syrj\u00e4nen (Barretos-SP, Brazil) (40\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Prognostic value of tumor markers in malignant melanoma. <em>O. Topolcan<\/em>, I. Treskova, J. Windrichova, V. Treska, J. Kinkorova, R. Kucera and T. Kydlicek (Plzen, Czech Republic) (15\u2019)<\/span><\/li>\n<li><span style=\"color: #808080;\">Horizon 2020. J. Kinkorov\u00e1 (Pilsen, Czech Republic) (10\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">The clinical significance of acute phase proteins levels in non small cell lung cancers. <em>N. Tsoukalas,<\/em> C. Giaginis, M. Tolia, M. Kyriakou, I. Kostakis, E. Bournakis, A. Papakostidi, K. Ballasis, S. Theocharis, C. Chrystophyllakis, K. Liaskonis (Athens, Greece) (10\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Cytokine profiles of benign and malignant thyroid disease. <em>X. Provatopoulou<\/em>, D. Georgiadou, E. Kalogera, G. Georgiou, T.N. Sergentanis, G.N. Zografos, A. Gounaris (Athens, Greece) (10\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>28. IMAGE-GUIDED RADIOTHERAPY<br \/>\nSpecial Symposium of the International Geriatric Radiotherapy Group (IGRG)<br \/>\nOrganized by N.P. Nguyen<\/h4>\n<h5><span style=\"color: #666699;\">ROOM B, 15.15-19.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair persons: N.P. Nguyen, U. Karlsson<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Elderly and cancer care. U. Karlsson (Marshfield, WI, USA)(40\u2019)<em><br \/>\n<\/em><\/span><\/li>\n<li><span style=\"color: #888888;\">The role of image-guided radiotherapy in dose escalation for locally advanced non-small cell lung cancer. <em>A. Chi,<\/em> N.P. Nguyen (Morgantown, WV, USA) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Treatment planning comparison between HDR &amp; IMRT for early stage breast cancer using SAVI technique. <em>S.R. Bose<\/em>, N.P. Nguyen (Washington, DC, USA) (30\u2019)<em><br \/>\n<\/em><\/span><\/li>\n<li><span style=\"color: #888888;\">The potential of image-guided radiotherapy for normal organs sparing in patients with locally advanced head and neck cancer. <em>N.P Nguyen,<\/em> A. Chi, V. Vinh-Hung, O. Gorobets, S. Bose, U. Karlsson (Washington, DC, USA) (25\u2019)<em><br \/>\n<\/em><\/span><\/li>\n<li><span style=\"color: #888888;\">Feasibility of image-guided radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer. <em>N.P. Nguyen<\/em>, S. Kratz, A. Chi, J. Vock, P. Vos, W. Shen, V. Vinh-Hung, L. Ewell, S. Jang, G. Altdorfer, U. Karlsson, J. Godinez, W. Woods, S. Dutta, F. Ampil (Washington, DC; Tucson, AZ; Morgantown; Parkersburg, WV; Greenville, NC; Marshfield, WI; Jacksonville, FL; Salisbury, MD; Shreveport, LA; San Antonio, TX, USA; Martinique, France; Lindenhofspital, Switzerland) (25\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_B\/Ahmed\/Ahmed.html\" target=\"_blank\" rel=\"noopener\">Studies on human cells irradiated with two radiation modalities (IMRT or conventional RT) show different molecular and cellular responses: public health implications. <em>F.E. Ahmed,<\/em> P.W. Vos, R.R. Allison, C. Jeffries (Greenville; Chapel Hill, NC, USA) (30\u2019)<\/a><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>29. EXPERIMENTAL CHEMOTHERAPY<\/h4>\n<h5><span style=\"color: #666699;\">ROOM C, 08.00-12.15 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: G. Ciarimboli, J. Haybaeck<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_C\/Ciarimboli\/Ciarimboli.html\" target=\"_blank\" rel=\"noopener\">Organic cation transporters mediate cisplatin and oxaliplatin side effects. <em>G. Ciarimboli,<\/em> J. Sprowl, A. Hucke, A. Zehnhoff-Dinnesen, A. Sparreboom, E. Schlatter(M\u00fcnster, Germany; Memphis, TN, USA) (30\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_C\/Helke\/Helke.html\" target=\"_blank\" rel=\"noopener\">Pitfalls of mouse cancer models (know your mouse). K. Helke (Charleston, SC, USA) (30\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_C\/Bonucci\/Bonucci.html\" target=\"_blank\" rel=\"noopener\">Intergrative oncology: Use of natural substances in oncology treatment: Useful,possible, valid. M. Bonucci (Rome, Italy) (40\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">The JAK\/STAT pathway is activated in gallbladder carcinoma. E. Lederer, J. Petzold, R. Reihs, C. Ernst, K. Bettermann, R. Moriggl, M.Schlederer, L. Kenner, S. Lax, P. Obrist, Y.N. Park, K.Sik Kim, S. Flechsig, J. Hoffmann, <em>J. Haybaeck<\/em> (Graz; Vienna; Zams, Austria; Seoul, South Korea; Berlin, Germany) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Acetylcarnitine potentiates the anticarcinogenic effects of butyrate. I. Elimrani, S. Dionne, D. Saragosti, I. Qureshi, L. Levy, E. Delvin, <em>E.G. Seidman<\/em> (Montreal, Quebec, Canada) (15\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Morphine, melatonin, marijuana, magnolia and myrrh as the \u201cfive m\u201d schedule in the treatment of cancer pain and the possible dose-dependency of the antitumor and analgesic effects of the pineal hormone melatonin. <em>P. Lissoni,<\/em> G. Porro, G. Messina, E. Porta, F. Rovelli, M.G. Roselli, F. Brivio (Milan, Italy) (20\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_C\/Kiss\/Kiss.html\" target=\"_blank\" rel=\"noopener\">Placental alkaline phosphatase to treat tumors as well as associated weight loss and muscle wasting. Z. Kiss (Austin, MN; La Jolla, CA, USA; Budapest, Hungary) (30\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Invitro and pH sensitive properties of calcium carbonate nanocrystal as novel delivery carrier for tamoxifen in estrogen receptor breast cancer cell line MCF-7. <em>A.S. Kamba,<\/em> A.L. Argungu, A.B.Z. Zuki (Serdang, Selangor, Malaysia) (15\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_C\/Massina\/Massina.html\" target=\"_blank\" rel=\"noopener\">A psychobiological approach in the treatment of advanced cancer-related pleasure deficiency. G. Messina (Milano, Italy) (20\u2019)<\/a><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>30. CYTOGENETICS AND GENETICS<\/h4>\n<h5><span style=\"color: #666699;\">ROOM C, 13.00-15.30 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: D.-T. Bau, E. De Breakeleer, S. Ingvarsson<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">BAC analysis of chromosomal translocation breakpoints: an efficient strategy for identifying new candidate genes in malignant hemopathies. N. Douet-Guilbert, E. De Breakeleer, C. Tous, N. Gueganic, M.J. Le Bris, A. Basinko, <em>M. De Braekeleer<\/em> (Brest, France) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_C\/Ingvarsson\/Ingvarsson.html\" target=\"_blank\" rel=\"noopener\">The genetic landscape of familial breast cancer in Iceland. S. Ingvarsson (Reykjavik, Iceland) (30\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Identification of PRRC1-MLL, a novel fusion gene, in a case of therapy-related acute lymphoblastic leukemia. N. Douet-Guilbert, C. Meyer, J.R. Eveillerd, V. Ugo, M.J. Le Bris, A. Basinko, F. Morel, R. Marschalek, <em>M. De Braekeleer<\/em> (Brest, France; Mail, Germany) (15\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Effects of Ataxia telangiectasia mutated (ATM) genotypes and personal smoking status on lung cancer risk in Taiwan. <em>S.-C. Wang<\/em>, W.-S. Chang, C.-M. Hsu, C.-W. Tsai, D.-T. Bau (Taichung, Taiwan, ROC) (15\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Evaluation of the contribution of methylenetetrahydrofolate reductase genotypes to Taiwan breast cancer. <em>C.-Y. Huang,<\/em> W.-S. Chang, C.-W. Tsai, C.-M. Hsu, C.-L. Hsiao, D.-T. Bau (Taichung; Taipei, Taiwan, ROC) (10\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">The genotype\/phenotype study for the role of caveolin-1 in gastrointestinal tract cancers. <em>C. M. Hsu<\/em>, W.-S. Chang, H.-X. Ji,C.-W. Tsai, D.-T. Bau (Taichung, Taiwan, ROC) (20\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>31. CARCINOGENESIS<\/h4>\n<h5><span style=\"color: #666699;\">ROOM C, 15.45-19.10 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: G.R. Rutteman, H.C.R. Wang<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Reactive oxygen species-mediated breast cell carcinogenesis enhanced by chronic exposure to multiple carcinogens and intervened by dietary agents. <em>H.C.R. Wang<\/em>, L.A. Pluchino (Knoxville, Tennessee, USA) (40\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\"><em>Helicobacter pylori<\/em>: Multitalented adaptation of binding properties. T. Bor\u00e9n (Umea, Sweden) (40\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Molecular biological and genetic investigations of cancers in companion animals can provide important insight in (rare) cancers in the human. G.R. Rutteman (Utrecht; Wageningen, The Netherlands) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">The role of the ECL cell in gastric carcinogenesis.<em> H.L. Waldum<\/em>, \u00d8. Hauso, \u00d8. S\u00f8rdal, R. Fossmark (Trondheim, Norway)(20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">A preliminary mutagenesis study of camphor in human leukocytes culture. <em>J.C. Santos,<\/em> M.F. Bellini (Bauru, Brazil) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Silver nanoparticles increase the ionic permeability of the pleura and partially inhibit the migration of pleural mesothelial cells. <em>V. Arsenopoulou,<\/em> P.A. Molyvdas, K. Gourgoulianis, C. Hatzoglou, S.G. Zarogiannis (Larissa, Greece) (10\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>32. MICROENVIROMENTAL HETEROGENEITY OF BRAIN TUMOURS: DYNAMIC TOPOGRAPHICAL CHANGES AND ADAPTATION TO THERAPIES<br \/>\nSpecial Symposium Organized by G. Pilkington and H. Fillmore<\/h4>\n<h5><span style=\"color: #666699;\">ROOM D, 8.00-15.30 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: C. Herold-Mende, H. Fillmore, G. Pilkington<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Introduction<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_D\/Pilkington\/Pilkington.html\" target=\"_blank\" rel=\"noopener\">Urban and rural communities, transport modalities, differing cultures and climate change &#8211; The admixture which defines the brain tumour micro-environment. G. Pilkington (Portsmouth, UK) (30\u2019)<\/a><\/li>\n<\/ul>\n<p><strong> Part 1. Microenvironmental drivers of glioma heterogenecity and therapeutic resistance: Antiogenesis<\/strong><br \/>\n<span style=\"color: #800000;\"><em><strong>Chair Person: C. Herold-Mende<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Adaptive mechanisms to anti-vascular therapy. R. Bjerkvig (Bergen, Norway) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">The perivascular glioma niche and its role in therapeutic resistance: safe harbour or active participant? H. Fillmore (Portsmouth, UK) (30\u2019)<\/span><\/li>\n<\/ul>\n<p><strong> Part 2: Microenvironmental drivers of therapeutic resistance: Immune-mediated resistance<\/strong><br \/>\n<span style=\"color: #800000;\"><em><strong>Chair Person: H. Fillmore<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Contribution of the immunological microenvironment on GBM survival. C. Herold-Mende (Heidelberg, Germany)(30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Mesenchymal stem cells affect glioblastoma cells upon direct contact. <em>H. Motaln,<\/em> J. Schuchhard, K. Stec, B. Breznik, H. Ulrich, T.T. Lah (Sao Paulo, Brazil; Ljublijana, Slovenia) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Paradoxical role of mesenchymal stem cells in glioblastomas microenvironment. <em>H. Motaln,<\/em> J. Schuchhardt, K. Stec, B. Breznik, H. Ulrich and T.T. Lah (Potsdam; Berlin, Germany; Sao Paulo, SP, Brazil; Ljublijana, Slovenia) (20\u2019)<\/span><\/li>\n<\/ul>\n<p><strong> Part 3. Post-doctoral and student presentations (10 min + 5 min discussion)<\/strong><br \/>\n<span style=\"color: #800000;\"><em><strong>Chair Person: G. Pilkington<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">T cell target repertoire in primary and recurrent glioblastomas. <em>C. Rapp<\/em>, R. Warta, S. Stamova, P. Beckhove, M. Schn\u00f6lzer, C. Herold-Mende (Heidelberg, Germany) (10\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Mitochondrial DNA mutations and brain tumour heterogeneity: Insights from three dimensional structural analysis. <em>K. Keatley<\/em>, R.E Lloyd, Q. An, H.L. Fillmore, G. J. Pilkington, J.E. McGeehan (Portsmouth, UK) (10\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">CD15 and E-selectin mediate adhesion of non-small cell lung cancer cells to brain endothelium. <em>S.A. Jassam<\/em>, Z. Maherally, J. Smith, K. Ashkan, H.L. Fillmore and G.J. Pilkington (Portsmouth, UK) (10\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Trick or treat: Impact of the microenvironment on the infiltration of T-cells in lower grade gliomas. <em>S. Dettling,<\/em> A. Moch, C. Geinsenberger, L. Hartmann L, A. von Deimling A, C. Herold-Mende (Heidelberg, Germany) (10\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Deacetylation of GD3A as a potential therapeutic strategy for paediatric medulloblastoma. <em>R. Mather<\/em>, K. Stephenson, H.L. Fillmore, G.J. Pilkington (Portsmouth, UK) (10\u2019)<\/span><\/li>\n<\/ul>\n<p><strong> Part 4. Microenvironmental impact on the cross-talk between glioma cells, immune cells and antiogenesis in glioblastoma: Potential combinational targets (Round table discussion)<\/strong><br \/>\n<span style=\"color: #800000;\"><em><strong>Chair persons: H. Fillmore, C. Herold-Mende, R. Bjerkvig , G. Pilkington<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Experimental questions\/design to explore potential micro-environmental therapeutic targets; Challenges and EU collaborative proposals (ie. COST)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>33. IMMUNOTHERAPY; BIOTHERAPY; VACCINES<\/h4>\n<h5><span style=\"color: #666699;\">ROOM D, 15.45-19.10 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair persons: F. Guadagni, K. Hellstrand, J. Koch<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/10_oct\/room_D\/Hellstrand\/Hellstrand.html\" target=\"_blank\" rel=\"noopener\">Natural killer cell expression ofnatural cytotoxicity receptors determines relapse risk in elderly patients with acute myeloid leukemia undergoing immunotherapy with histamine dihydrochloride and interleukin-2. A. Martner, A. Rydstr\u00f6m, R.E. Riise, J. Aurelius, M. Brune, R. Fo\u00e0, <em>K. Hellstrand,<\/em> F.B. Thor\u00e9n (Rome, Italy) (20&#8242;)<\/a><\/li>\n<li><span style=\"color: #808080;\">Histamine promotes the differentiation of dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase. <em>A. Martner,<\/em> B. Lenox, H. Grauers Wiktorin, J. Aurelius, F. Ewald, E. Aydin, F.B. Thor\u00e9n, S. Hermodsson, K. Hellstrand (Gothenburg, Sweden) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_D\/Koch\/Koch.html\" target=\"_blank\" rel=\"noopener\">The SR\/CR mouse model of cancer resistance. J. Koch (Copenhagen,Denmark) (20\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_D\/Nishikata\/Nishikata.html\" target=\"_blank\" rel=\"noopener\">Unique activated state of U937 derived macrophage. H. Ishii, M. Ishikawa, T. Inoue, Y. Sumiya, Y. Kobayashi, H. Kouda, T. Gotoh, S. Kasutani, T. Inui, D. Kuchiike, K. Kubo, Y. Uto, <em>T. Nishikata<\/em> (Kobe; Tokushima; Osaka, Japan) (15\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_D\/Ishikawa\/Ishikawa.html\" target=\"_blank\" rel=\"noopener\">Establishment and comparison of novel assay systems for activation of macrophage using two different types of human monocytic cell line.<em> M. Ishikawa<\/em>, H. Kouda, T. Inoue, T. Inui, D. Kuchiike, K. Kubo, Y. Uto, T. Nishikata (Kobe; Tokushima; Osaka, Japan) (15\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_D\/Tuyaerts\/Tuyaerts.html\" target=\"_blank\" rel=\"noopener\">Interaction of uterine tumors with the immune system: implications for immunotherapy. <em>S. Tuyaerts,<\/em> A. Vanderstraeten, T. Everaert, R. Van Bree, C. Luyten, G. Verbist, F. Amant (Leuven, Belgium) (30\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Vaccination with WT1 mRNA-electroporated dendritic cells to prevent relapse in 30 acute myeloid leukemia patients. <em>E.L. Smits<\/em> , A. Van de Velde, S. Anguille, Y. Willemen, W.A. Schroyens, A.P. Gadisseur, A. Verlinden, I. Vrelust, M. Lammens, G. Nijs, B. Stein, N. Cools, R. Malfait, M.B. Maes, K. Vermeulen, V.F. Van Tendeloo, Z.N. Berneman (Antwerp, Belgium) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_D\/Prinz\/Prinz.html\" target=\"_blank\" rel=\"noopener\">Critical role of Toll-like receptors and regulatory T-cells during Helicobacter pylori-induced immunity and gastric carcinogenesis. <em>C. Prinz<\/em>, K. Kakounis, R. Mej\u00edas-Luque, R. K\u00e4bisch and M. Gerhard (Witten; Munich, Germany) (30\u2019)<\/a><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>34. CHEMOPREVENTION. ENVIRONMENTAL EXPOSURE AND CANCER RISK<\/h4>\n<h5><span style=\"color: #666699;\">ROOM E, 8.00-12.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: W. Weber, B. Davidson<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Familial cancer and prevention. W. Weber (Basel, Switzerland) (20\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_E\/Williamson\/Williamson.html\" target=\"_blank\" rel=\"noopener\">A review of risk factors in urothelial cancer. D. Curry, M. Ruddock, S. Dalleau, G. Kennedy, B. Duggan, H. O\u2019Kane, C. Reid, <em>K. Williamson<\/em> (Belfast, UK) (20\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Molecular backgrounds of chemoprevention: selenite, phenolics, chalcones. P. Perj\u00e9si (Pecs, Hungary) (20\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_E\/Davidson\/Davidson.html\" target=\"_blank\" rel=\"noopener\">The incidence of cancer mortality in the Caribbean region from 2006 to 2012. B. Davidson (Anguilla, British West Indies) (20\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Carotenoids and their derivatives prevent cancer by affecting the activity of diverse transcription systems. J. Levy (Beer-Sheva, Israel) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Plant-derived micronutrients inhibit estrogenic and IGF-1 activity in breast cancer cells but not in bone cells. Y. Sharoni (Beer Sheva, Israel) (20\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>35. BREAST CANCER: PATHOLOGY AND IMAGING<br \/>\nSpecial Symposium Organized by N.J. Agnantis<\/h4>\n<h5><span style=\"color: #666699;\">ROOM E, 13.00-15.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: N.J. Agnantis<\/strong><\/em><\/span><br \/>\n<em>Round Table<\/em><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_E\/Batistatou\/Batistatou.html\" target=\"_blank\" rel=\"noopener\">Pathogenesis of mammary microcalcifications. A. Batistatou (Ioannina, Greece) (20\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_E\/Geranou\/Geranou.html\" target=\"_blank\" rel=\"noopener\">Breast calcifications: Imaging. A. Vourtsi (Athens, Greece) (20\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_E\/Nonni\/Nonni.html\" target=\"_blank\" rel=\"noopener\">Vacuum-assisted biopsy (VAB) and pathology. A. Nonni (Athens, Greece) (20\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_E\/Karydas\/Karydas.html\" target=\"_blank\" rel=\"noopener\">The role of Surgeon in microcalcifications of the breast. I. Karydas (Athens, Greece) (20\u2019)<\/a><\/li>\n<\/ul>\n<p><em>Discussion(10\u2019)<\/em><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_E\/Goussia\/Goussia.html\" target=\"_blank\" rel=\"noopener\">Columnar cell lesions of the breast. A.C. Goussia (Ioannina, Greece) (30\u2019)<\/a><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>36. CANCER STEM CELLS<br \/>\nSpecial Symposium Organized by M. Jhanwar-Uniyal, G. Sica<\/h4>\n<h5><span style=\"color: #666699;\">ROOM E, 15.15-19.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: G. Sica, M. Jhanwar-Uniyal<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Cancer stem cells: secret and promises. G. Sica (Rome, Italy) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_E\/Scatena\/Scatena.html\" target=\"_blank\" rel=\"noopener\">Mesenchymal stromal\/ stem cells (MSCs) and cancer stem cells (CSCs), a tangled interrelationship with intriguing pathophysiological and clinical implications. <em>R. Scatena<\/em>, P. Bottoni, F. Iacopino, G. Sica (Rome, Italy) (40\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">Characterization of signaling pathways associated with cancer stem cells of glioblastoma multiforme. M. Jhanwar-Uniyal (New York, NY, USA) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">A new way to think about tumor stem cells. <em>J.A. Radosevich,<\/em> B.T. Murphy, X. Wei, K.M. Elseth, Z.Deliu, M.Aqil, M. Bassiony (Chicago, IL, USA) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Alterations in DNA topoisomerases activity in cancer stem cells and in bacterial infected tumor cells influence the efficacy of anti-cancer agents. <em>E. Priel,<\/em> R. Peleg, R.Afriat, Y. Mizrachi-Nebentzahl, S. Horowitz (Beer-Sheva, Israel) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Proteome-based personalized anti-tumor cell therapy. <em>A.S.Bryukhovetskiy,<\/em> I.S. Bryukhovetskiy (Moscow, Russian Federation) (15\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>37. NEW INSIGHTS IN RENAL CANCER<br \/>\nSpecial Symposium of SIUrO Organized by G. Sica and G. Conti<\/h4>\n<h5><span style=\"color: #666699;\">ROOM F, 8.00-14.00 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: G. Sica, G. Martorana<\/strong><\/em><\/span><br \/>\n<strong><em>Welcome address by Giario Conti, SIUrO President<\/em><\/strong><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Precision medicine in renal cancer: Biomarker and genomic profile studies. G.L. Pappagallo (Venice, Italy) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Genomics in translational research and targeted therapies in Renal Cancer. S.C. Jhanwar (New York, NY, USA) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Martignoni\/Martignoni.html\" target=\"_blank\" rel=\"noopener\">Toward a new histo-pathological classification of renal tumours. <em>G. Martignoni<\/em>, D. Segala (Verona, Italy) (30\u2019)<\/a><\/li>\n<li><span style=\"color: #888888;\">New methods in evaluation of VHL gene. <em>E. Bollito,<\/em> S. Vatrano, S. Cappia (Turin, Italy) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Martorana\/Martorana.html\" target=\"_blank\" rel=\"noopener\">Radical nephrectomy versus partial nephrectomy in localized renal cell carcinoma. G. Martorana (Bologna, Italy) (30\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Lapini\/Lapini.html\" target=\"_blank\" rel=\"noopener\">Renal biopsy, mininvasive techniques and active surveillance in small renal tumors. A. Lapini (Florence, Italy) (30\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Salvioni\/Salvioni.html\" target=\"_blank\" rel=\"noopener\">The role of surgery in locally advanced or metastatic renal cell carcinoma (rcc). R. Salvioni (Milan, Italy) (30\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Porta\/Porta.html\" target=\"_blank\" rel=\"noopener\">First line medical therapy in advanced metastatic RCC. <em>C. Porta<\/em>, P. Giglione, F. Lombardo, C. Paglino (Pavia, Italy) (20\u2019)<span style=\"color: #ff6600;\"><em><br \/>\n<\/em><\/span><\/a><\/li>\n<\/ul>\n<p><em> Conclusion : G. Conti<\/em><\/p>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>38. MULTI-DRUG AND DRUG RESISTANCE: MECHANISMS AND REVERSAL<\/h4>\n<h5><span style=\"color: #666699;\">ROOM F, 14.15-16.15 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Person: L. Amaral, G. Giamas<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Sgaragli\/Sgaragli.html\" target=\"_blank\" rel=\"noopener\">ATP-binding cassette (ABC) transporters are still important drug targets for combating multidrug-resistant cancer cells. G. Sgaragli (Siena, Italy) (30\u2019)<\/a><span style=\"color: #ff6600;\"><em><br \/>\n<\/em><\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Koberle\/Koberle.html\" target=\"_blank\" rel=\"noopener\">Platinum (IV)nitroxyl complexes as possible candidates to circumvent cisplatin resistance in bladder cancer cells. M. Cetraz, V. Sen, A. Hartwig, <em>B. K\u00f6berle<\/em>, (Karlsruhe, Germany) (25\u2019)<\/a><span style=\"color: #ff6600;\"><em><br \/>\n<\/em><\/span><\/li>\n<li><span style=\"color: #888888;\">Nitric oxide donor-doxorubicins as MDR reversing agents. <em>E. Gazzano<\/em>, K. Chegaev, I. Pedrini , J. Kopecka, B. Rolando, R. Fruttero, S. Arpicco, D. Ghigo, C. Riganti (Torino, Italy) (20\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Frosini\/Frosini.html\" target=\"_blank\" rel=\"noopener\">Mitochondrial-targeting nitrooxy-doxorubicin: effects on P-glycoprotein and assessment of their vascular effects. <em>M. Frosini,<\/em> V. Maestrini, A. Neri, C. Santulli, C. Brizi, K. Chegaev, C. Riganti, G. Sgaragli, N.A. Colabufo, S. Saponara (Siena; Torino; Bari, Italy) (10\u2019)<\/a><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Saponara\/Saponara.html\" target=\"_blank\" rel=\"noopener\">Screening for potential hazard effects from multitarget anthracycline on cardiovascular system. <em>S. Saponara,<\/em> M. Durante, M. Frosini, B. Gorelli, M. Valoti, K. Chegaev, G. Sgaragli, F. Fusi F (Siena; Torino, Italy) (10\u2019)<\/a><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<h4>39. NEW ANTICANCER AGENTS<\/h4>\n<h5><span style=\"color: #666699;\">ROOM F, 16.30-19.30 &#8211; Tuesday, October 7<\/span><\/h5>\n<hr style=\"width: 100%; color: #ffffff; border: 1px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n<p><span style=\"color: #800000;\"><em><strong>Chair Persons: A. Bhushan, H.M. Warenius<\/strong><\/em><\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li><span style=\"color: #888888;\">Tyrosine phosphorylation: Role in antifolate resistance. <em>A. Bhushan,<\/em> T. Liu, P. Sheridan and J.C.K. Lai (Philadelphia, PA, USA) (30\u2019)<\/span><\/li>\n<li><a href=\"https:\/\/www.heystack.gr\/IIAR\/congress_video\/7_oct\/room_F\/Warenius\/Warenius.html\" target=\"_blank\" rel=\"noopener\">Global anticancer targets: still a possibility? H.M. Warenius (Southampton, UK) (30\u2019)<\/a><span style=\"color: #ff6600;\"><em><br \/>\n<\/em><\/span><\/li>\n<li><span style=\"color: #888888;\">Brk\/PTK6 as a novel therapeutic target in breast cancer. R.S. Burmi, G.A. Box, C.J. Pennington, J.A. Davies, W.J. Court, S.A. Eccles, D.R. Edwards, <em>A. Harvey<\/em> (Uxbridge, UK) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Identification and design of new C5-DNA methyltransferase inhibitors and their biological activity. P.B. Arimondo (Toulouse, France) (30\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Exploiting the potential of lipids and frogs foams to treat Cancer. D.A. Lamprou (Glasgow, Scotland, UK) (20\u2019)<\/span><\/li>\n<li><span style=\"color: #888888;\">Initial evaluation of a CD146\/MUC18 targeting radioimmunoconjugate. <em>S. Westr\u00f8m<\/em>, N. Abbas, R.H. Larsen, O.S. Bruland, T.J. Jonasdottir, T.B. B\u00f8nsdorff (Oslo, Norway) (10\u2019)<\/span><\/li>\n<\/ul>\n<hr style=\"width: 100%; color: #ffffff; border: 3px solid #CCCCCC;\" noshade=\"noshade\" width=\"100%\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Tuesday, October 7 (The presenters of gray titles did not allow the online appearance of their lectures ) 22. MOLECULAR AND CELLULAR BIOLOGY OF CANCER ROOM A, 08.00-12.00 &#8211; Tuesday, October 7 Chair Persons: R.M. Hoffman, F.E. Ahmed, P. Kumar Cell cycle decoy with Salmonella typhimurium A1-R to convert tumors from chemo-resistant to sensitive. S. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-6819","page","type-page","status-publish","czr-hentry"],"_links":{"self":[{"href":"https:\/\/conferences.iiar-suppl.com\/index.php?rest_route=\/wp\/v2\/pages\/6819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/conferences.iiar-suppl.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/conferences.iiar-suppl.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/conferences.iiar-suppl.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/conferences.iiar-suppl.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6819"}],"version-history":[{"count":13,"href":"https:\/\/conferences.iiar-suppl.com\/index.php?rest_route=\/wp\/v2\/pages\/6819\/revisions"}],"predecessor-version":[{"id":182006,"href":"https:\/\/conferences.iiar-suppl.com\/index.php?rest_route=\/wp\/v2\/pages\/6819\/revisions\/182006"}],"wp:attachment":[{"href":"https:\/\/conferences.iiar-suppl.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}